Marquette General Cancer Center

 

Head and Neck

 

Study Name - ECOG E1305

 

Study Description -

A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer.

 

IRB Open Date - 03/04/2011

 

Consent

 

Data Privacy Statement for Research Studies

 

 

 

<< Back